During the past decade, Azienda Ospedaliera Carlo Poma conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 6 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera Carlo Poma" #1 sponsor was "National Cancer Institute, Naples" with 7 trials, followed by "European Institute of Oncology" with 3 trials sponsored, "IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Bial - Portela C S.A." with 2 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Carlo Poma" #1 collaborator was "Clinical Research Technology S.r.l." with 2 trials as a collaborator, "Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente" with 2 trials as a collaborator, "Aventis Pharmaceuticals" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Clinical Trials Promoting Group (APRIC/CTPG)" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Carlo Poma" are "Breast Cancer" (4 trials), "Coronary Artery Stenosis" (3 trials), "Dravet Syndrome" (3 trials), "Ovarian Cancer" (3 trials) and "Advanced Non-Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Azienda Ospedaliera Carlo Poma" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera Carlo Poma" are "Drug" (24 trials), "Device" (7 trials), "Other" (6 trials), "Procedure" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (4 trials), "ZX008 (Fenfluramine Hydrochloride)" (3 trials), "adjuvant therapy" (3 trials), "fluorouracil" (3 trials) and "gemcitabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera Carlo Poma" are 32 trials for "All" genders, 9 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera Carlo Poma". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Azienda Ospedaliera Carlo Poma, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera Carlo Poma, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 5 trials that are defined as “Not Applicable".

Azienda Ospedaliera Carlo Poma has several departments that took part in Clinical trials: "Az. Osp. Carlo Poma; Divisione Di Oncologia Medica" - 9 trials